Literature DB >> 35221483

Combined Dipeptidyl Peptidase 4 Inhibitor and α-Glucosidase Inhibitor Treatment in Postprandial Hypoglycemia.

David T Broome1, Alimitha Kodali1, Danielle Phillips2, Vinni Makin1, Daniel Mendlovic1, Robert S Zimmerman1.   

Abstract

Entities:  

Year:  2022        PMID： 35221483      PMCID： PMC8865782          DOI： 10.2337/cd21-0042

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN： 0891-8929


× No keyword cloud information.
  17 in total

Review 1.  [Reactive hypoglycaemia, a mysterious, insidious but non dangerous critical phenomenon].

Authors:  A J Scheen; P J Lefèbvre
Journal:  Rev Med Liege       Date:  2004-04

Review 2.  The use of acarbose in the prevention and treatment of hypoglycaemia.

Authors:  P J Lefebvre; A J Scheen
Journal:  Eur J Clin Invest       Date:  1994-08       Impact factor: 4.686

Review 3.  Postprandiol hypoglycemia.

Authors:  M A Permutt
Journal:  Diabetes       Date:  1976-08       Impact factor: 9.461

4.  Sitaglitpin phosphate treatment in patients with reactive hypoglycemia secondary to dysinsulinism. Controlled,zzm321990randomized, double-blind study.

Authors:  Daniel Cuevas-Ramos; Paloma Almeda-Valdés; Clara E Meza-Arana; Griselda Brito-Córdova; Doris Georgina Ruiz-Gómez; Christian Razo; Francisco J Gómez-Pérez
Journal:  Gac Med Mex       Date:  2017       Impact factor: 0.302

Review 5.  Postprandial reactive hypoglycemia.

Authors:  J F Brun; C Fedou; J Mercier
Journal:  Diabetes Metab       Date:  2000-11       Impact factor: 6.041

Review 6.  Efficacy and safety of combination therapy with an α-glucosidase inhibitor and a dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta-analysis.

Authors:  Se Hee Min; Jeong-Hwa Yoon; Seokyung Hahn; Young Min Cho
Journal:  J Diabetes Investig       Date:  2017-10-25       Impact factor: 4.232

Review 7.  Global status of diabetes prevention and prospects for action: A consensus statement.

Authors:  Mahmoud Ibrahim; Jaakko Tuomilehto; Pablo Aschner; Lucille Beseler; Avivit Cahn; Robert H Eckel; Amy Hess Fischl; George Guthrie; James O Hill; Mick Kumwenda; R David Leslie; Darin E Olson; Paolo Pozzilli; Sandra L Weber; Guillermo E Umpierrez
Journal:  Diabetes Metab Res Rev       Date:  2018-06-08       Impact factor: 4.876

8.  Acarbose in reactive hypoglycemia: a double-blind study.

Authors:  J Gérard; A S Luyckx; P J Lefèbvre
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1984-01

9.  Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.

Authors:  Julio Rosenstock; James E Foley; Marc Rendell; Mona Landin-Olsson; Jens J Holst; Carolyn F Deacon; Erika Rochotte; Michelle A Baron
Journal:  Diabetes Care       Date:  2007-10-18       Impact factor: 19.112

10.  Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal.

Authors:  Zhong Chen; Xiaoying Fu; Jian Kuang; Ju Chen; Hongmei Chen; Jianhao Pei; Huazhang Yang
Journal:  BMC Endocr Disord       Date:  2016-09-29       Impact factor: 2.763
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.